Implication of ionotropic glutamate receptors in the release of noradrenaline in hippocampal CA1 and CA3 subregions under oxygen and glucose deprivation

Neurochemistry International

Volumn 43, Issue 6, 2003, Pages 543-550

  Milusheva, E A ^a,b   Baranyi, M ^b  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

AMPA receptor; Hippocampus; In vitro; Ischemia; NMDA receptor; Noradrenaline release

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 4 AMINOBUTYRIC ACID; AMPA RECEPTOR ANTAGONIST; ASPARTIC ACID; CALCIUM ION; DIZOCILPINE; GLUCOSE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; OXYGEN;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; BRAIN REGION; CONTROLLED STUDY; CYTOPLASM; DENTATE GYRUS; DRUG SELECTIVITY; GLUCOSE UTILIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LOW TEMPERATURE; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

EID: 0038005299     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(03)00081-0     Document Type: Article

References (55)

1. Adam-Vizi V. External calcium independent release of neurotransmitters. J. Neurochem. 58:1992;395-405.
2. Arias R.L., Tasse J.R., Bowlby M.R. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia. Brain Res. 816:1999;299-308.
3. Arvin B., Lekieffre D., Graham J.L., Moncada C., Chapman A.G., Meldrum B.S. Effect of the non-NMDA receptor antagonist GYKI 52466 on the microdialysate and tissue concentrations of amino acids following transient forebrain ischaemia. J. Neurochem. 62:1994;1458-1467.
4. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentration of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
5. Bhardwaj A., Brannan T., Martinez-Tica J., Weinberger J. Ischemia in the dorsal hippocampus is associated with acute extracellular release of dopamine and norepinephrine. J. Neural Trans.: Gen. Sect. 80:1990;195-201.
6. Blomqvist P., Lindvall O., Wieloch T. Lesions of the locus coeruleus system aggravate ischemic damage in the rat brain. Neurosci. Lett. 58:1985;353-358.
7. Burke S.P., Nadler J.V. Effect of glucose deficiency on glutamate/aspartate release and excitatory synaptic responses in the hippocampal CA1 area in vitro. Brain Res. 500:1989;333-342.
8. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
9. Connick J.H., Stone T.W. Excitatory amino acid antagonists and endogenous aspartate and glutamate release from rat hippocampal slices. Br. J. Pharmacol. 93:1988;863-867.
10. Erecinska M., Nelson D., Wilson D.F., Silver I.A. Neurotransmitter amino acids in the CNS. I. Regional changes in amino acid levels in rat brain during ischemia and reperfusion. Brain Res. 304:1984;9-22.
11. Erecinska M., Nelson D., Silver I.A. Metabolic and energetic properties of isolated nerve ending particles (synaptosomes). Biochim. Biophys. Acta. 2177:1996;13-34.
12. Fredholm B.B., Dunwiddie T.V., Bergman B., Lindstrom K. Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res. 295:1984;127-136.
13. Freeman G.B., Mykytyn V., Gibson G.E. Differential alteration of dopamine, acetylcholine and glutamate release during anoxia and/or 3,4-diaminopyridine treatment. Neurochem. Res. 12:1987;1019-1027.
14. Gibson G.E., Manger T., Toral-Barza L., Freeman G. Cytosolic-free calcium and neurotransmitter release with decreased availability of glucose or oxygen. Neurochem. Res. 14:1989;437-443.
15. Globus M.Y.T., Busto R., Dietrich P., Martinez E., Valdes I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1988;1455-1464.
16. Globus M.Y., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D. Direct evidence for an acute and massive norepinephrine release in the hippocampus during transient ischemia. J. Cerebral Blood Flow Metabolism. 9:1989;892-896.
17. Hauptman M., Nelson D., Wilson D.F., Erecinska M. Neurotransmitter amino acids in the CNS. II. Some changes in amino acid levels in rat brain synaptosomes during and after in vivo anoxia and stimulated ischemia. Brain Res. 304:1984;23-35.
18. Hortnagl H., Berge M.L., Sperk G., Pifl Ch. Regional heterogenity in the distribution of neurotransmitter markers in the rat hippocampus. Neuroscience. 45:1991;261-272.
19. 2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemia and anoxia. Neuroscience. 27:1988;175-182.
20. Madl J.E., Royer S.M. Glutamate in synaptic terminals is reduced by lack of glucose but not hypoxia in rat hippocampal slices. Neuroscience. 94:1999;417-430.
21. Mally J., Baranyi M., Vizi E.S. Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. J. Neural Trans.: Gen. Sect. 103:1996;71-73.
22. 2+ concentration by presynaptic glutamate receptors in hippocampus. Br. J. Pharmacol. 113:1994;1439-1447.
23. Malva J.O., Ambrosio A.F., Cunha R.A., Ribeiro J.A., Carvalho A.P., Carvalho C.M. A functionally active presynaptic high-affinity kainate receptor in the rat hippocampal CA3 subregion. Neurosci. Lett. 185:1995;83-86.
24. Martin D., Bustos G.A., Bowe M.A., Bray S.D., Nadler J.V. Autoreceptor regulation of glutamate and aspartate relase from slices of the hippocampus CA1 area. J. Neurochem. 56:1991;1647-1655.
25. Massieu L., Gomez-Roman N., Montiel T. In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate. Exp. Neurol. 165:2000;257-267.
26. Milusheva E., Doda M., Pasztor E., Lajtha A., Sershen H., Vizi E.S. Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. J. Neurochem. 59:1992;946-952.
27. Milusheva E., Baranyi M., Zelles T., Mike A., Vizi E.S. Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3, and dentate gyrus regions. Eur. J. Neurosci. 6:1994;187-192.
28. 3H ]dopamine in striatal slices of the rat Neurochem. Int. 28:1996;501-507.
29. 3H )glutamate binding sites in rat brain J. Neurosci. 5:1985;2909-2919.
30. Nadler J.V., Evenson D.A., Cuthbertson G.J. Comparative toxicity of kainic acid and other excitatory amino acids toward rat hippocampal neurons. Neuroscience. 6:1981;2505-2517.
31. Nadler J.V., Martin D., Bustos G.A., Burke S.P., Bowe M.A. Regulation of glutamate and aspartate release from the Schaffer collaterals and other projections of CA3 hippocampal pyramidal cells. Prog. Brain Res. 83:1990;115-130.
32. 3H ]noradrenaline and glutamate in response to simulation of ischemic condition in rat spinal cord slice preparation. Effect of NMDA and AMPA receptor antagonists Eur. J. Pharmacol. 366:1999;143-150.
33. Oleskevich S., Descarries L., Lacaille J.C. Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat. J. Neurosci. 9:1989;3803-3815.
34. Phillis J.W., Walter G.A. Hypoxia/hypotension evoked release of glutamate and aspartate from the rat cerebral cortex. Neurosci. Lett. 106:1989;147-151.
35. Pittaluga A., Raiteri M. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur. J. Pharmacol. 191:1990;231-234.
36. Pittaluga A., Raiteri M. N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Exp. Therapeutics. 260:1992;232-237.
37. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischemia is mainly by reversed uptake. Nature. 403:2000;316-321.
38. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
39. 2+-independent release of glutamate during anoxia in isolated nerve terminals (synaptosomes). J. Neurochem. 50:1988;1322-1324.
40. Santos M.S., Moreno A.J., Carvalho A.P. Relationships between ATP depletion, membrane potential, and the release of neurotransmitters in rat nerve terminals. Stroke. 27:1996;941-950.
41. Schmidt-Kastner R., Freund T.F. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 40:1991;599-636.
42. Siesjo B.K. Historical overview: calcium, ischemia, and death of brain cells. Ann. N.Y. Acad. Sci. 522:1988;638-661.
43. Stys P.K., LoPachin R.M. Mechanisms of calcium and sodium fluxes in anoxic myelinated central nervous system axons. Neuroscience. 82:1998;21-32.
44. Szerb J.C. Changes in the relative amounts of aspartate and glutamate released and retained in hippocampal slices during stimulation. J. Neurochem. 50:1988;219-224.
45. Tretter L., Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 20:2000;8972-8979.
46. + channel block prevents the ischemia-induced release of norepinephrine from spinal cord slices. Eur. J. Pharmacol. 346:1998;145-150.
47. Virgili M., Contestabile A., Barnabei O. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia. Hippocampus. 5:1995;91-97.
48. 2+) activated ATPase, of acetylcholine release in cortical slices from rat brain. J. Physiol. (London). 226:1972;95-117.
49. + activated adenosinetriphosphatase as a trigger in transmitter release. Neuroscience. 3:1978;367-384.
50. Vizi E.S. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochem. Int. 33:1998;359-366.
51. Vizi E.S. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev. 52:2000;63-89.
52. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 8:1998;566-607.
53. Wang J.K.T., Andrews H., Thukral V. Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals. J. Neurochem. 58:1992;204-211.
54. 2+ in rat hippocampal slices. Brain Res. 813:1998;351-358.
55. Yao H., Matsumoto T., Hirano M., Uchimura H., Ooboshi H., Sadoshima S., Fujishima M. Striatal glutamic acid and gamma-aminobutyric acid in transient cerebral ischemia in spontaneously hypertensive rats. Jpn. Heart J. 31:1990;385-392.